These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 4382573)
1. [Results of treatment with Tavegil in dermatology]. Nasemann T Med Welt; 1966 Dec; 51():2798-800. PubMed ID: 4382573 [No Abstract] [Full Text] [Related]
2. [Clinical and allergological evaluation of Tavegil (HS-592), a new antihistaminic drug]. Bogdaszewska-Czabanowska ; Starzycki Z Przegl Dermatol; 1969; 56(5):659-65. PubMed ID: 4391299 [No Abstract] [Full Text] [Related]
3. [Treatment of various allergic diseases in children with histaglobin]. Lokotkina EA; Iakobson MI; Lukash NI; Ivanova EI; Popova RP Vopr Okhr Materin Det; 1972 Apr; 17(4):91-2. PubMed ID: 4404217 [No Abstract] [Full Text] [Related]
4. Levocetirizine (Xyzal) for allergic rhinitis and urticaria. Med Lett Drugs Ther; 2007 Dec; 49(1275):97-9. PubMed ID: 18046285 [No Abstract] [Full Text] [Related]
5. [Experience with a new antihistaminic in dermatology. Results of a clinical double blind trial]. Eberhartinger C; Ebner H Wien Med Wochenschr; 1969 Sep; 119(38):630-2. PubMed ID: 4390510 [No Abstract] [Full Text] [Related]
6. [The antihistaminic Tavegil--therapeutic test for the role of histamine in dermatoses]. Dietz H; Feige R Med Welt; 1967 Sep; 35():2054-7. PubMed ID: 4174624 [No Abstract] [Full Text] [Related]
7. [Clinical and experimental studies with the antihistaminic Tavegyl in dermatologic patients]. Grabner K Wien Klin Wochenschr; 1970 Sep; 82(36):625-7. PubMed ID: 4396798 [No Abstract] [Full Text] [Related]
8. [H1 antihistamines. Actions, adverse effects, administration]. Polk B Med Monatsschr Pharm; 2005 Apr; 28(4):114-6. PubMed ID: 15850248 [No Abstract] [Full Text] [Related]
9. [Ambulatory testing of a new antihistaminic. Experience with Tavegil]. Weitgasser H Munch Med Wochenschr; 1967 May; 109(20):1134-6. PubMed ID: 4384702 [No Abstract] [Full Text] [Related]
10. Focusing into new challenges in allergic rhinitis and urticaria. Introduction. Valero Santiago AL J Investig Allergol Clin Immunol; 2011; 21 Suppl 3():1. PubMed ID: 22185043 [No Abstract] [Full Text] [Related]
11. [Treatment of vasomotoric rhinitis with the new histamine blocking agents Tavegil]. Flechsig H Landarzt; 1967 Jul; 43(19):931-2. PubMed ID: 4389309 [No Abstract] [Full Text] [Related]
12. [Clinical evaluation of a new antihistaminic agent--Tavergyl]. Beritić T Lijec Vjesn; 1971; 83(9):1065-70. PubMed ID: 4403703 [No Abstract] [Full Text] [Related]
13. Astemizole--another non-sedating antihistamine. Med Lett Drugs Ther; 1989 May; 31(791):43-4. PubMed ID: 2565524 [No Abstract] [Full Text] [Related]
14. [Tavegil-Sandoz (antihistamicum) in the treatment of several dermatological itching entities]. Wanic A Pol Tyg Lek; 1968 Oct; 23(44):1701-3. PubMed ID: 4387381 [No Abstract] [Full Text] [Related]
15. [Antihistamines. How safe are they?]. MMW Fortschr Med; 2002 Sep; 144(37):53. PubMed ID: 12380340 [No Abstract] [Full Text] [Related]
16. [Experience with the Tavegil therapy of chronic pruritic dermatoses]. Somov BA; Butov IuS; Vinokurov IN; Berezhnoi IuZ; Kulagin VI Sov Med; 1972 Apr; 35(4):124-6. PubMed ID: 4145547 [No Abstract] [Full Text] [Related]
17. [Histryl--a new antihistaminic drug]. Bernhardt E Przegl Dermatol; 1969; 56(4):501-3. PubMed ID: 4390954 [No Abstract] [Full Text] [Related]
18. [Therapeutic value of antihistamines today. Dermatoses and allergic diseases of the mucous membranes]. Stüttgen G; Blitstein-Willinger E; Rudolph R Z Hautkr; 1984 Mar; 59(6):355-66. PubMed ID: 6144211 [TBL] [Abstract][Full Text] [Related]
19. [Clinical evaluation of a new antihistaminic: HS-592]. von Bernath Z Prensa Med Argent; 1971 Jul; 58(21):1071-5. PubMed ID: 4398545 [No Abstract] [Full Text] [Related]
20. H1-antihistamines in the elderly. Kaliner MA Clin Allergy Immunol; 2002; 17():465-81. PubMed ID: 12113227 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]